-
![Derivatives of octahydro-6,10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds](/abs-image/US/2002/09/12/US20020128473A1/abs.jpg.150x150.jpg)
1.发明申请Derivatives of octahydro-6,10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds 有权八氢-6,10-二氧代-6H-哒嗪并[1,2-a] [1,2]二氮杂-1-羧酸的衍生物，其制备方法及其在制备治疗活性化合物中的用途公开(公告)号：US20020128473A1
公开(公告)日：2002-09-12
申请号：US10102591
申请日：2002-03-20
申请人： Aventis Pharma S.A.
IPC分类号： A61K031/5513
CPC分类号： C07K5/06139 , Y02P20/55
摘要： Novel intermediates of the formulae 1 where the substituents are defined as in the specification.
摘要翻译： 取代基如说明书中定义的式的新型中间体
-
2.发明申请Novel process and intermediates for preparing 17-halogenated 19-norsteroid compounds 有权用于制备17-卤代19-降胆甾醇化合物的新工艺和中间体公开(公告)号：US20040224933A1
公开(公告)日：2004-11-11
申请号：US10834638
申请日：2004-04-29
申请人： Aventis Pharma S.A.
IPC分类号： C07J043/00 , A61K031/58
摘要： The invention relates to a process for preparing compounds of formula (I): 1 in which R1, R2, R3, n and X are as defined in the description, and to the intermediate compounds for implementing this process.
摘要翻译： 本发明涉及一种制备式（I）化合物的方法：其中R1，R2，R3，n和X如说明书中所定义，以及用于实施该方法的中间体化合物。
-
![Derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds](/abs-image/US/2003/07/10/US20030130269A1/abs.jpg.150x150.jpg)
3.发明申请Derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds 审中-公开八氢-6,10-二氧代-6H-哒嗪并[1,2-a] [1,2]二氮杂-1-甲酸的衍生物，其制备方法及其在制备治疗活性化合物中的用途公开(公告)号：US20030130269A1
公开(公告)日：2003-07-10
申请号：US10313422
申请日：2002-12-06
申请人： Aventis Pharma S.A.
IPC分类号： A61K031/551 , C07D487/04
CPC分类号： C07K5/06139 , Y02P20/55
摘要： A compound of the formula 1 of SR configuration or a SRnullSS wherein R is selected from the group consisting of hydrogen, alkyl of up to 18 carbon atoms and aryl and aralkyl of up to 18 carbon atoms and the nullNH2 is free or protected useful as intermediates.
摘要翻译： SR构型或SR + SS的化合物，其中R选自氢，最多18个碳原子的烷基和至多18个碳原子的芳基和芳烷基，-NH 2是有用的或有保护的 作为中间体。
-
4.发明申请Novel chiral compounds derived from hexanoic acid esters, preparation process and intermediates, use in the synthesis of chiral 2-(bromomethyl)-2-ethylhexanoic acid 审中-公开衍生自己酸酯的新型手性化合物，制备方法和中间体，用于合成手性2-（溴甲基）-2-乙基己酸公开(公告)号：US20040147774A1
公开(公告)日：2004-07-29
申请号：US10737955
申请日：2003-12-17
申请人： Aventis Pharma S.A.
IPC分类号： C07C069/52
CPC分类号： C07C69/34 , C07B2200/07 , C07C51/09 , C07C51/363 , C07C53/19 , C07C59/01
摘要： A subject matter of the invention is a chiral compound of formula 1 where R1 is hydroxyl or a group which activates the carboxyl and R2 is alkyl optionally substituted by halogen or benzyl, its preparation, its application in the synthesis of chiral 2-bromomethyl-2-ethylhexanoic acid and novel intermediates.
摘要翻译： 本发明的主题是式的手性化合物，其中R 1是羟基或活化羧基的基团，R 2是任选被卤素或苄基取代的烷基，其制备，其在合成手性2-溴甲基-2- 乙基己酸和新型中间体。
-
-
-
搜索结果
4 条记录 (耗时 0.01 秒)
